Preparation of STX-ge: To a solution of STX-hexylamine tris-heptafluorobutyrate (1.5 mg, 1.4 µmol) in 250 µL of a 1:3 mixture of pH 9.5 buffer (0.1 M NaHCO 3 /Na 2 CO 3 ) and MeCN was added the glycerol ether N-hydroxysuccinimide ester (1.9 mg, 4.6 µmol, 3.3 equiv). The solution was stirred for 2.25 h at room temperature, then acidified with 1 mL of 0. Human tissue: Human skin samples were obtained from four patients undergoing plastic surgery at Stanford Medical School. All patients gave written informed consent following approved IRB protocols.
S2 skin specimen, which was then placed in a shallow dish partially filled with synthetic interstitial fluid. The surface of the skin was carefully handled and dried prior to compound application. Confined circular treatment areas (d = 1 cm) were created by delineating the application area with ink and surrounding the site with Vaseline. For each application site, 25 nmol of compound was applied in 25 µL of vehicle. After 1, 4 or 10 hours of application, the skin was frozen in a -80 o C freezer. Five different compounds were tested on human skin: lidocaine (Sigma Aldrich), aconitine, saxitoxin, STX-ge, and BTX-A
derivative. The two vehicles tested were ethanol (Fisher) and DMSO (Fisher).
UV burn injury:
Confined circular treatment areas of the human skin samples were exposure to UV (300 to 450 nm, 3100mJ/cm 2 ) irradiation before application of the compound. UV light was directly applied to skin over 25s [1] using the BlueWave® 200 Version 3.0 UV Curing Spot Lamp with Intensity Adjustment (Dymax Inc., Torrington, CT). After UV exposure, 25 nmol of compound was applied in 25 µL of vehicle to each application site. After 4 hours of application, the skin was frozen in a -80 o C freezer.
Animals:
Animal experiments were conducted using ~300 g male Sprague Dawley rats. The hair on the back of the rats was removed 24 h before drug application. Under urethane anesthesia, confined 
DESI Imaging:
A lab-built DESI-MS imaging ion source coupled to a LTQ-Orbitrap mass spectrometer was used for tissue imaging. Mass spectra were acquired in the positive ion mode using Orbitrap as the mass analyzer at 60,000 resolving power in the range m/z 100 -1100. Pure acetonitrile (Fisher) was used as the histologically compatible solvent system for DESI-MSI at a flow rate of 2 µL/min, and S3 nitrogen gas pressure of 175 psi. The tissue sections were scanned using a 2D moving stage with spatial resolution of 100 µm or 150 µm. The software ImgGenerator (freeware, http://www.msimaging.net/) was used for converting raw files into 2D images. Spatially accurate ion images were assembled using BioMap software (freeware, http://www.maldi-msi.org/).
Histology:
After DESI-MS imaging, the same tissue sections were stained using standard hematoxylin and eosin (H&E). H&E stained tissue sections were evaluated by veterinary pathologist Dr. Richard
Luong. Optical images of the H&E stained tissue sections were obtained using a microscope Axioskop 2 Plus (Carl Zeiss International, Thornwood, NY) and digitally overlaid with DESI-MS ion images for compounds depth penetration calculation.
Supporting Tables   Table S1 . Tentative identification of ions detected from human skin using high mass resolution/high mass accuracy and tandem mass spectrometry analyses. [b] Molecular formulas of the protonated or sodium/potassium adducts of the assigned molecules.
[c] Mass errors were calculated based on the exact monoisotopic m/z of the protonated or sodium/potassium adducts of the assigned molecules. Table S2 . Average penetration depth in human and rat skins for each compound studied using different vehicles.
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Human Skin
Vehicle Figure S4 . DESI-MS ion images showing the penetration of BTX-A, aconitine and lidocaine using ethanol as vehicle applied to human skin after UV burn. 
